Izalontamab brengitecan, an EGFR and HER3 bispecific antibody–drug conjugate, versus chemotherapy in heavily pretreated recurrent or metastatic nasopharyngeal carcinoma: a multicentre, randomised, open-label, phase 3 study in China

Journal:
The Lancet
Published:
DOI:
10.1016/s0140-6736(25)01954-3
Affiliations:
33
Authors:
35
Go to article
Institutions Authors Share
Biokin Pharma, China
4.000000
 0.12
State Key Laboratory of Oncology in South China, SYSUCC, China
3.000000
 0.09
Tumor Hospital of Guangxi Medical University, China
1.000000
 0.03
Sun Yat-sen University Cancer Center (SYSUCC), SYSU, China
1.000000
 0.03
Jiangmen Central Hospital, China
1.000000
 0.03
Zhejiang Cancer Hospital (ZJCH), China
1.000000
 0.03
People's Hospital of Guangxi Zhuang Autonomous Region, China
1.000000
 0.03
The First Affiliated Hospital of Nanchang University, China
1.000000
 0.03
First Affiliated Hospital, GDPU, China
1.000000
 0.03
The First Affiliated Hospital of Fujian Medical University, China
1.000000
 0.03
SystImmune, United States of America (USA)
1.000000
 0.03
Wuzhou Red Cross Hospital, China
1.000000
 0.03
Hunan Cancer Hospital, China
1.000000
 0.03
Zhangzhou Municipal Hospital of Fujian Province, China
1.000000
 0.03
Second Affiliated Hospital of Guilin Medical University, China
1.000000
 0.03
Jiangxi Provincial Cancer Hospital, China
1.000000
 0.03
Wuhan Union Hospital, HUST, China
1.000000
 0.03
Foshan First People's Hospital, China
1.000000
 0.03
Dongguan People's Hospital, China
1.000000
 0.03
Shanghai East Hospital, Tongji University, China
1.000000
 0.03
Affiliated Cancer Hospital of Guangzhou Medical University, China
1.000000
 0.03
Cancer Hospital and Shenzhen Hospital, CAMS & PUMC, China
1.000000
 0.03
Zhongshan City People's Hospital, China
1.000000
 0.03
Guigang City People's Hospital, China
1.000000
 0.03
Fudan University Shanghai Cancer Center (FUSCC), China
1.000000
 0.03
Hospital and Cancer Center, CQU, China
1.000000
 0.03
PLA No. 900 Hospital of the Joint Support Force (PLA No. 900 Hospital), China
1.000000
 0.03
Sichuan Cancer Hospital, China
0.500000
 0.01
University of Electronic Science and Technology of China (UESTC), China
0.500000
 0.01
Fujian Medical University, China
0.500000
 0.01
Fujian Cancer Hospital, China
0.500000
 0.01
Interested in Oncology and Carcinogenesis?